Author:
Davis Joy M.,Rushton Tullia,Nsiah Felicity,Stone Rebecca L.,Beavis Anna L.,Gaillard Stéphanie L.,Dobi Alice,Fader Amanda N.
Reference12 articles.
1. Undifferentiated carcinoma of the endometrium;Altrabulsi;Am J Surg Pathol.,2005
2. Clinical and biological activity of chemoimmunotherapy in advanced endometrial Adenocarcinoma: a phase II trial of the big ten cancer Research consortium;Barber;Cancer Res Commun.,2022
3. Pembrolizumab plus chemotherapy in advanced endometrial cancer;Eskander;N Engl J Med.,2023
4. FDA grants accelerated approval to pembrolizumab for first tissue/site agnostic indication. U.S. Food & Drug Administartion. Published May 30, 2017. Accessed January 28, 2024. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-pembrolizumab-first-tissuesite-agnostic-indication.
5. Lenvatinib plus pembrolizumab for advanced endometrial cancer;Makker;N Engl J Med.,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pembrolizumab;Reactions Weekly;2024-06-29